The impact of the recent HIV non-nucleoside reverse transcriptase inhibitors and nucleoside reverse transcriptase inhibitors-based regimens on metabolic health outcomes: A narrative review

The global prevalence of human immunodeficiency virus (HIV) has led to a significant rise in the chronic use of antiretroviral (ARV) drugs, both for HIV management and pre-exposure prophylaxis (PrEP), to meet the set Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets. Although anti...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	Amogelang Sedibe, Ntethelelo Sibiya, Trevor Nyakudya, Mlindeli Gamede
Formáid:	Artigo
Teanga:	Inglês
Foilsithe / Cruthaithe:	Elsevier 2025-12-01
Sraith:	Biochemistry and Biophysics Reports
Ábhair:	HIV- antiretroviral therapy HIV-Fixed-dose combination therapy Prediabetes Type 2 diabetes mellitus Drug-metabolic complications Pancreatic health outcomes
Rochtain ar líne:	http://www.sciencedirect.com/science/article/pii/S2405580825004327
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!